PRDX4 and renal carcinoma: Other osteoclastogenesis mediators, including peroxiredoxin-4 (PRDX4) and L-plastin (LPC1), have been identified as responsible for tumor bone colonization in a number of osteotropic cancers such as breast, prostate, and renal cancers (22).